Radiation therapy for the gynecologic oncologist
- PMID: 41289794
- DOI: 10.1016/j.ygyno.2025.10.030
Radiation therapy for the gynecologic oncologist
Abstract
Radiation therapy for the gynecologic oncology patient has evolved in the last century but continues to be an integral component of care for women with pelvic malignancies. This review discusses the essential aspects of physics, radiobiology, and imaging for radiation therapy. It aims to review the increasing indications for radiation therapy in gynecologic neoplasms such as for oligometastatic disease and palliative measures. It also discusses the widespread adoption of IMRT, increasing use of SBRT and proton beam therapy, and modernization of brachytherapy in gynecological cancer, while also touching on the interdigitation of immunotherapy, as well as the impact of molecular factors in adjuvant endometrial cancer treatment. Radiation oncology, like other oncologic disciplines, continues to evolve to provide less morbidity with improved outcomes and experience for our patients. And thus, the following review discusses innovations in radiotherapy used in gynecologic malignancies today and the advances we see impacting the field of gynecologic oncology moving forward.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest Dr. David Gaffney is the NRG Oncology Gynecology co-chair, Board Member of IGCS, Associate Editor of Gynecologic Oncology, DSMC chair for Merck cervix study, and has Clinical Trial funding from Elekta on Vaginal brachytherapy. But all other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. During the preparation of this work, the authors did not use any generative AI or AI-assisted technologies in the writing process.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
